71 results
8-K
ADAP
Adaptimmune Therapeutics Plc
15 May 24
Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
7:14am
customary closing and commitment fees, prepayment fees and provisions, events of default and representations, warranties and affirmative and negative
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
your role, you should discuss these matters with the chairman.
TIME COMMITMENT
You will be expected to devote such time as is necessary for the proper … commitment. You may be required to devote additional time to the Company in respect of preparation time for meetings and ad hoc matters that may arise
8-K
EX-10.3
istjep00orjafd2z55
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
qms9ejj
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-99.1
tpyev8pze7bp30cek7xu
9 Sep 22
Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors
7:14am
8-K
EX-10.1
k0a69ybqyb
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-99.1
0983hu vut
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am